Black Rock Inc. Ligand Pharmaceuticals Inc Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
290Shares Held
19.5MCall Options Held
9KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA2.09MShares$346 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$176 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$153 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$124 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX705KShares$117 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.79B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...